Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
Q1 2026 earnings • 8:00 AM tomorrow
See details
BNTX:NASDAQ
BioNTech SE - ADR
99,35 USD
+1,86%
(+1,81) 1D
101,64 USD
+2,30% (+2,29)
After hours
Closed: 4-май, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNTX...
Open
98,88 USD
High
100,21 USD
Low
95,42 USD
Mkt. cap
25,12 млд
Avg. vol.
880,00 миң
Volume
1,05 млн
52-wk high
123,98 USD
52-wk low
79,52 USD
EPS
-5,51 USD
Beta
1,34
Shares outstanding
252,88 млн
No. of employees
8 миң
News stories
From sources across the web
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes. In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR
CEOUğur Şahin
Employees7,81 миң
Founded2008
Headquarters-
Sector-
Websitebiontech.de
Next call in 11:16:59
Tomorrow, 08:00
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-1,92 est.)EUR
Revenue / Estimate
-/ (155,38 млн est.)EUR
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
182,80 млн
260,80 млн
1,52 млд
907,40 млн
Cost of goods sold
83,80 млн
76,40 млн
148,30 млн
302,80 млн
Cost of revenue
83,80 млн
76,40 млн
148,30 млн
302,80 млн
Research and development expenses
525,60 млн
509,10 млн
564,80 млн
505,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120,60 млн
137,40 млн
148,50 млн
217,90 млн
Operating expense
593,40 млн
621,10 млн
1,40 млд
907,20 млн
Total operating expenses
677,20 млн
697,50 млн
1,55 млд
1,21 млд
Operating income
-494,40 млн
-436,70 млн
-33,00 млн
-302,60 млн
Other non operating income
122,60 млн
105,40 млн
96,80 млн
-173,80 млн
EBT including unusual items
-445,40 млн
-402,70 млн
24,70 млн
-227,40 млн
EBT excluding unusual items
-419,50 млн
-379,30 млн
40,70 млн
-206,50 млн
Income tax expense
-29,60 млн
-16,10 млн
53,40 млн
77,60 млн
Effective tax rate
6,65%
4,00%
216,19%
-34,12%
Other operating expenses
-52,80 млн
-25,40 млн
690,30 млн
183,90 млн
Net income
-415,80 млн
-386,60 млн
-28,70 млн
-305,00 млн
Net profit margin
-227,46%
-148,24%
-1,89%
-33,61%
Earnings per share
-1,73
-1,60
-0,12
-0,33
Interest and investment income
-
-
-
265,50 млн
Interest expense
-7,90 млн
-6,60 млн
-2,60 млн
-
Net interest expenses
-7,90 млн
-6,60 млн
-2,60 млн
265,50 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-451,60 млн
-385,70 млн
91,20 млн
-266,95 млн
Gain or loss from assets sale
-100,00 миң
-300,00 миң
-1,30 млн
-800,00 миң
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer